Related Experiment Video
Updated: Jul 16, 2026

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
Published on: September 11, 2015
The EGF receptor Hokey-Cokey
Dan Niculescu-Duvaz1, Steven Whittaker, Caroline Springer
1The Institute of Cancer Research, Gene and Oncogene Targeting Team, Cancer Research UK Centre for Cancer Therapeutics, Sutton, Surrey SM2 5NG, UK.
Abstract:
In cancer, the epidermal growth factor (EGF) receptor (EGFR) can be activated by mutations that disrupt the inactive conformation and allow the active conformation to predominate. Structural studies have elucidated the molecular events that lead to EGFR activation and shown that small-molecule anti-EGFR drugs can bind to either the inactive or the active conformation of the kinase domain. In this issue of Cancer Cell, Yun et al. present 12 crystal structures of the wild-type or mutant forms of the EGFR kinase domain bound to four different ligands. This study will prove invaluable to those developing novel anti-EGFR drugs.
Insights
Structural insights into epidermal growth factor receptor (EGFR) activation reveal how mutations and drug binding stabilize active or inactive states. This research aids in developing targeted anti-EGFR cancer therapies.
Area of Science:
- Oncology
- Structural Biology
- Pharmacology
Background:
- Epidermal growth factor receptor (EGFR) mutations drive cancer by promoting an active conformation.
- Small-molecule drugs targeting EGFR can bind to its inactive or active states.
Purpose of the Study:
- To elucidate the structural basis of EGFR activation and drug binding.
- To provide insights for developing novel anti-EGFR therapeutics.
Main Methods:
- X-ray crystallography was used to determine 12 structures.
- Structures included wild-type and mutant EGFR kinase domains bound to four distinct ligands.
Main Results:
- Detailed structural information on EGFR kinase domain conformations.
- Visualizations of drug interactions with both active and inactive EGFR states.
Conclusions:
- The presented structures offer a valuable resource for rational drug design.
- Understanding EGFR conformational dynamics is key for effective cancer treatment development.
More Related Videos
Related Concept Videos
Receptor Tyrosine Kinases
Cell-surface Signaling
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Mitogens and the Cell Cycle
Mitogens and the Cell Cycle

